Compare AMPX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPX | HAE |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | United States | United States |
| Employees | 109 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | N/A | 1996 |
| Metric | AMPX | HAE |
|---|---|---|
| Price | $11.57 | $75.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $20.17 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 7.3M | 871.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $76.15 | N/A |
| Revenue Next Year | $59.65 | $5.23 |
| P/E Ratio | ★ N/A | $36.59 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.09 | $47.32 |
| 52 Week High | $24.23 | $87.32 |
| Indicator | AMPX | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 35.81 | 60.56 |
| Support Level | $10.00 | $72.04 |
| Resistance Level | $14.54 | $80.90 |
| Average True Range (ATR) | 1.16 | 2.68 |
| MACD | -0.14 | -0.51 |
| Stochastic Oscillator | 6.39 | 54.12 |
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. Its silicon anodes are a direct drop-in replacement of the graphite anode in traditional lithium-ion batteries, and its manufacturing processes leverage the manufacturing processes for conventional lithium-ion batteries and the related supply chain.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.